Lv11
30 积分 2023-04-13 加入
结直肠癌分子病理检测临床实践指南(2025版)
8小时前
待确认
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer
28天前
已完结
[Expert consensus on clinical application of next-generation sequencing in advanced breast cancer (2024 edition)]
1个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
1个月前
已完结
Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
2个月前
已完结
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC
2个月前
已完结
Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis
3个月前
已完结
Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC
3个月前
已完结
[China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)]
4个月前
已完结
Diagnosis, Treatment Patterns, and Outcomes in Real-World Patients with RET Fusion-Positive Non-small Cell Lung Cancer in China
5个月前
已完结
皖公网安备34019202002308
